Schweizerhall Drug Launch in Germany Delayed

July 18, 2008 |

1 min read

ZURICH, July 17 (Reuters) - Switzerland' Schweizerhall said on Thursday the market launch of its blood-thinning drug Clopidogrel, a copy-cat version of Sanofi-Aventis and Bristol-Myers Squibb's Plavix drug, will be delayed.

Regulatory Europe

MORE ON THIS TOPIC

Health and Human Services Secretary Robert F. Kennedy Jr. makes remarks at an event announcing the MAHA (Make America Healthy Again) Commission, Thursday, May 22, 2025, in the East Room of the White House. (Official White House Photo by Joyce N. Boghosian)

Legal

Medical Groups Sue RFK Jr. Over ‘Baseless and Uninformed’ Changes to COVID-19 Vaccine Policy

July 8, 2025

·

2 min read

·

Tristan Manalac

Success to win in business competition, overcome obstacles or motivation to solve problem and lead company achievement concept, confident businessman leader jump high over 3 hurdles to be winner.

Approvals

KalVista Wins OK for First On-Demand Hereditary Angioedema Pill

July 7, 2025

·

2 min read

·

Tristan Manalac

Entrance to the U.S. Department of Health and Human Services in Washington, DC

Layoffs

HHS Cuts and Rehires by the Numbers: What We Know About Kennedy’s Overhaul

July 7, 2025

·

3 min read

·

Tristan Manalac

Close-Up Of Syringe With Bottles Against Blue Background

RSV

Kennedy Follows RSV Recommendations of ACIP Members He Fired

July 3, 2025

·

3 min read

·

Tristan Manalac